Masimo Corporation – LSE:0JZ2.L
Masimo stock price today
Masimo stock price monthly change
Masimo stock price quarterly change
Masimo stock price yearly change
Masimo key metrics
Market Cap | 9.07B |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | 1.5 |
Revenue | 1.97B |
EBITDA | 264.9M |
Income | 79.1M |
Revenue Q/Q | -12.77% |
Revenue Y/Y | -13.96% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | 13.41% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMasimo stock price history
Masimo stock forecast
Masimo financial statements
| Jul 2023 | 455.3M | 15.7M | 3.45% |
|---|---|---|---|
| Sep 2023 | 478.9M | 10.6M | 2.21% |
| Dec 2023 | 548.9M | 33.9M | 6.18% |
| Mar 2024 | 492.8M | 18.9M | 3.84% |
| Sep 2025 | 540.36M | 51.64M | 9.56% |
|---|---|---|---|
| Oct 2025 | 543.67M | 54.11M | 9.95% |
| Dec 2025 | 637.94M | 69.53M | 10.9% |
| Mar 2026 | 549.11M | 55.09M | 10.03% |
Analysts Price target
Financials & Ratios estimates
| Jul 2023 | 3011200000 | 1.70B | 56.55% |
|---|---|---|---|
| Sep 2023 | 2995900000 | 1.72B | 57.42% |
| Dec 2023 | 3041500000 | 1.67B | 55.13% |
| Mar 2024 | 2957700000 | 1.59B | 53.84% |
| Jul 2023 | 23.6M | -22.4M | -4.9M |
|---|---|---|---|
| Sep 2023 | -7M | -22.4M | 19.3M |
| Dec 2023 | 77.1M | -25.3M | -36.3M |
| Mar 2024 | 45.8M | -18.9M | -26.5M |
Masimo alternative data
| Aug 2023 | 4,000 |
|---|---|
| Sep 2023 | 4,000 |
| Oct 2023 | 4,000 |
| Nov 2023 | 4,000 |
| Dec 2023 | 4,000 |
| Jan 2024 | 4,000 |
| Feb 2024 | 4,000 |
| Mar 2024 | 3,800 |
| Apr 2024 | 3,800 |
| May 2024 | 3,800 |
| Jun 2024 | 3,800 |
| Jul 2024 | 3,800 |
Masimo other data
| Insider | Compensation |
|---|---|
Mr. Joseph E. Kiani (1965) Founder, Chief Executive Officer & Chairman | $3,000,000 |
| Mr. Bilal Muhsin (1981) Chief Operating Officer | $892,510 |
| Mr. Anand Sampath (1966) Executive Vice President of Operations & Clinical Research | $774,840 |
| Mr. Thomas Samuel McClenahan (1973) Executive Vice President, Gen. Counsel & Corporation Sec. | $718,050 |
| Mr. Micah Young (1979) Executive Vice President of Fin. & Chief Financial Officer | $713,370 |
Dr. Steven J. Barker (1945) Chairman of Scientific Advisory Board, Chief Science Officer & Director | $190,000 |
| Mr. Yongsam Lee Executive Vice President & Chief Information Officer | |
Mr. Eli Kammerman Vice President of Bus. Devel. & Investor Relations | |
Mr. J. Todd Koning Senior Vice President & Chief Accounting Officer | |
| Mr. Jon Coleman Pres of Worldwide Sales, Professional Services & Medical Affairs |
-
What's the price of Masimo stock today?
One share of Masimo stock can currently be purchased for approximately $97.74.
-
When is Masimo's next earnings date?
Unfortunately, Masimo's (0JZ2.L) next earnings date is currently unknown.
-
Does Masimo pay dividends?
No, Masimo does not pay dividends.
-
How much money does Masimo make?
Masimo has a market capitalization of 9.07B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 0.6% to 2.05B US dollars.
-
What is Masimo's stock symbol?
Masimo Corporation is traded on the LSE under the ticker symbol "0JZ2.L".
-
What is Masimo's primary industry?
Company operates in the Healthcare sector and Medical - Equipment & Services industry.
-
How do i buy shares of Masimo?
Shares of Masimo can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Masimo's key executives?
Masimo's management team includes the following people:
- Mr. Joseph E. Kiani Founder, Chief Executive Officer & Chairman(age: 60, pay: $3,000,000)
- Mr. Bilal Muhsin Chief Operating Officer(age: 44, pay: $892,510)
- Mr. Anand Sampath Executive Vice President of Operations & Clinical Research(age: 59, pay: $774,840)
- Mr. Thomas Samuel McClenahan Executive Vice President, Gen. Counsel & Corporation Sec.(age: 52, pay: $718,050)
- Mr. Micah Young Executive Vice President of Fin. & Chief Financial Officer(age: 46, pay: $713,370)
- Dr. Steven J. Barker Chairman of Scientific Advisory Board, Chief Science Officer & Director(age: 80, pay: $190,000)
- Mr. Yongsam Lee Executive Vice President & Chief Information Officer
- Mr. Eli Kammerman Vice President of Bus. Devel. & Investor Relations
- Mr. J. Todd Koning Senior Vice President & Chief Accounting Officer
- Mr. Jon Coleman Pres of Worldwide Sales, Professional Services & Medical Affairs
-
Is Masimo founder-led company?
Yes, Masimo is a company led by its founder Mr. Joseph E. Kiani.
-
How many employees does Masimo have?
As Jul 2024, Masimo employs 3,800 workers.
-
When Masimo went public?
Masimo Corporation is publicly traded company for more then 7 years since IPO on 29 Jan 2018.
-
What is Masimo's official website?
The official website for Masimo is masimo.com.
-
Where are Masimo's headquarters?
Masimo is headquartered at 52 Discovery, Irvine, CA.
-
How can i contact Masimo?
Masimo's mailing address is 52 Discovery, Irvine, CA and company can be reached via phone at +94 92977000.
Masimo company profile:
Masimo Corporation
masimo.comLSE
3,800
Medical - Equipment & Services
Healthcare
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.
Irvine, CA 92618
:
ISIN: US5747951003
:
